|Send to printer »|
BioMarket Trends : Sep 15, 2012 ( )
Granular Look at Stem Cell Research
Review of Publication Trends Reveals Trajectory of the Space!--h2>
As part of our continuing review of the stem cells marketplace, we have sought to analyze and categorize the publications in the broad stem cell field in order to better understand relationships between specific stem cell classes and selected disease classes.
This methodology represents one metric by which the large and amorphous field of stem cell research can be analyzed. The method presented is just one part of our comprehensive coverage of this space, which uses various different metrics that en bloc allow us to closely follow a given market space.
From the PubMed database, we retrieved 144,317 unique publications with stem cell in the title or abstract of the publication. We subsequently binned these publications into stem cell classes based on the presence of specific stem cell descriptors. The Table presents this binning.
This set of binned publications was then used to generate a hotspot map utilizing various disease-related keywords that we utilized as a means to interrogate this pool of papers. The rationale was that these keywords could provide an insight into what these publications were focusing on and therefore what this publication record was telling us. Figure 1 presents the results of this hotspot analysis. The keywords used across the top of the table were focused on normal stem cell biology as well as pathological situations. The deeper the shading of a particular cell in this 2D map, the more publications segregate into this space.
In summary, it is clear that an analysis of the stem cell publication record can yield unique information about different market segments in a deeply granular manner that can be used as a metric to follow the growth, expansion, and maturation of this marketplace.
Figure 2 shows the massive expansion of the stem cell field over the past decades as assessed via number of publications, and our present analysis seeks to classify and categorize these publications in order to discover operative trends and reveal the trajectory of this expanding marketplace. We continue our coverage of this field as we map the evolution of the sector as research efforts move towards commercialization of stem cell products.
(firstname.lastname@example.org), is biotechnology analyst at Select Biosciences.
Web: www.selectbiosciences.com.Gary Oosta, Ph.D., is president of Emerging Tech Insights and Enal Razvi, P
© 2013 Genetic Engineering & Biotechnology News, All Rights Reserved